Expert Opinion on Investigational Drugs retweeted
Cefiderocol, a cephalosprin which targets siderophore uptake, suggested to have the potential to become first-line therapy for our most aggressive and lethal multidrug-resistant Gram-negative pathogens ncbi.nlm.nih.gov/pubmed/2931…
Expert Opinion on Investigational Drugs retweeted
BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations tandfonline.com/doi/full/10.…
Expert Opinion on Investigational Drugs retweeted
SLEEP disturbances & severe STRESS as GLIAL activators: psychoneuroimmunology model explaining central sensitization ncbi.nlm.nih.gov/pubmed/2868…
Expert Opinion on Investigational Drugs retweeted
Synaptic alterations associated with psychiatric disorders: potential as therapeutic target. dlvr.it/LHldXM
Expert Opinion on Investigational Drugs retweeted
Pubmed: Epigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 (ω-3)… dlvr.it/DKqZlC
Expert Opinion on Investigational Drugs retweeted
Article from our journal Expert Opinion on Therapeutic Targets in PubMed: tandfonline.com/doi/abs/10.1… teapawt.net/epigen_papers/status/6…
Pubmed: Epigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 (ω-3)… dlvr.it/DKqZlC
Expert Opinion on Investigational Drugs retweeted
Mir-221/222 are promising targets for innovative anticancer therapy. dlvr.it/KlCjCC
Expert Opinion on Investigational Drugs retweeted
Calreticulin, a therapeutic target? dlvr.it/Kl7Wkz
Expert Opinion on Investigational Drugs retweeted
Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging,… dlvr.it/Kpbf4l #breastcancer
Expert Opinion on Investigational Drugs retweeted
[LIVER] Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention. dlvr.it/KrzGxP
Expert Opinion on Investigational Drugs retweeted
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus 1.usa.gov/1SNv1lE
Expert Opinion on Investigational Drugs retweeted
An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A). dlvr.it/LJ0Hm9
Expert Opinion on Investigational Drugs retweeted
An Oncogenic Role of miR-592 in Tumorigenesis of Colorectal Cancer by Targeting FoxO3A ow.ly/Z5ur300bh9x
Expert Opinion on Investigational Drugs retweeted
Another reason to OK medical #marijuana. Cannaboids have anti-cancer effect. Stop cancer angiogenesis/metastasis ncbi.nlm.nih.gov/pubmed/2707…
Expert Opinion on Investigational Drugs retweeted
Today is #WorldBipolarDay and the Expert Collection is joining in! Check out our latest literature @ https://teapawt.net/t.co/8dkI2ZlUom #bipolar
Expert Opinion on Investigational Drugs retweeted
@iokijo Endocannabinoid signaling in female reproductive events: a potential therapeutic target? - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/2612…
Expert Opinion on Investigational Drugs retweeted
The potential of DISC1 protein as a therapeutic target for mental illness. dlvr.it/KKydCq
Expert Opinion on Investigational Drugs retweeted
Pubmed: Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases,… dlvr.it/DMKFrN
Expert Opinion on Investigational Drugs retweeted
Pharmacological effects of berberine and its derivatives: a patent update. - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/2661…
Expert Opinion on Investigational Drugs retweeted
Replying to @EO_InvDrugs
@EO_SarahOBW Excellent article Sarah. EZH2 inhibitors carry promise against two subtypes of ovarian cancer.



















